April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Study by diabetes expert describes promising type 1 treatments
February 14, 2019 | Katie Neith
A paper co-authored by Bart Roep, Ph.D., Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology at City of Hope, published in Nature explores new ways of replacing beta cells after too many of them have been killed by the immune system.
Researchers identify new target for potential type 1 diabetes treatment
October 18, 2018 | Katie Neith
Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.
Stem Cell Transplants Lead to Cure for Some Type 1 Diabetes Patients
March 1, 2017 | Katie Neith
A recent clinical trial monitored by City of Hope’s Bart Roep, Ph.D., showed promising results for a possible cure of type 1 diabetes (T1D). Although the study involved risky stem cell transplant procedures, it identified new paths for personalized therapies of T1D.
New Study Flips the Script on Cause of Type 1 Diabetes
February 27, 2017 | Katie Neith
For decades, scientists believed that the root cause of type 1 diabetes (T1D) was the immune system mistakenly identifying insulin secreting beta cells as a potential danger and, in turn, destroying them. Now, a study led by City of Hope’s Bart Roep turns that idea on its head.
‘Hidden History’: Legacy of Diabetes Care at City of Hope
January 25, 2017 | Katie Neith
City of Hope — widely known as a center for cancer care and research — is also the home of one of the most influential diabetes research programs in the world.
The Future of Diabetes: A Focus on Personalized Care
January 16, 2017 | Katie Neith
Diabetes affects over 422 million people worldwide according to the World Health Organization, but no two patients are alike. So in 2017 and beyond, treatments will increasingly make use of precision medicine to personalize treatment options. At City of Hope, researchers are combining the forces of a transformative gift with new resources to speed these treatments to patients.
Meet our doctors: Bart O. Roep on the future of diabetes research
February 22, 2016 | City of Hope
From his earliest days as a medical student, Bart O. Roep, PhD. had a goal – to find a cure for type 1 diabetes. Over the last 25 years, his quest has earned him numerous medical and scientific awards. Now, as the founding chair of the Department of Diabetes Immunology, located within the Diabetes & Metabolism Research Institute at City of Hope, Roep says he is excited to be working with like-minded partners to make this ambitious goal a reality.